|
Medication Therapy Management
Certificate Training Program
Sunday March 18, 2012
Centrastate Medical Center
Ambulatory Campus Auditorium
901 WestMain Street
Freehold, NJ 07728
Fee: NJPhA Member ($195) / Non-Member ($295)
Delivering Medication Therapy Management Services in the Community is an innovative and interactive training program that explores the pharmacist’s role in providing MTM services to patients. Pharmacists have a tremendous opportunity to receive reimbursement for monitoring and improving medication use in patients with complex medication regimens. This practice-based activity teaches pharmacists the essential skills necessary to become a successful MTM practitioner. The certificate training program will enhance pharmacists’ clinical expertise in evaluating complicated medication regimens, identifying medication-related problems, and making recommendations to patients, caregivers, and health care professionals. Delivering Medication Therapy Management Services in the Community is conducted in three parts: self-study activity and pre-seminar exercise; live interactive seminar; post-seminar exercise.
The American Pharmacists Association and the American Society of Consultant Pharmacists are accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.
Successful completion of the self-study learning component results in 10 hours of continuing pharmacy education credit (1.0 CEU), Universal Activity Number (UAN 202-999-09-006-H04-P). The live seminar is approved for 8 hours (0.8 CEU) of continuing pharmacy education credit (UAN 202-999-09-005-L04-P). The post-seminar exercise is approved for 3 hours (0.3 CEU) of continuing pharmacy education credit (UAN 202-999-09-007-H04-P). Initial Release Date: March 1, 2009; Expiration Date: March 1, 2012. For complete ACPE information, please go to www.pharmacist.com/ctp/mtm.
Delivering Medication Therapy Management Services in the Community was developed as a joint project by the American Pharmacists Association and the American Society of Consultant Pharmacists and originally supported in part by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Eisai Pharmaceuticals, Eli Lilly and Company, Janssen Pharmaceuticals, Ortho-McNeil Janssen Pharmaceuticals, sanofi-aventis, and Wyeth Pharmaceuticals.
|